Gilead Sciences Inc

NASDAQ: GILD
$113.99
-$0.44 (-0.4%)
Closing Price on March 12, 2025

GILD Articles

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by 2 to 1 and on...
October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by a slim margin...
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in Tuesday’s session. On the NYSE, decliners led advancers by about 7 to 1 and...
October 7, 2016: Here are four stocks trading with relatively heavy volume among 49 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by more than 2 to 1...
October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by a slight margin...
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
We liked the list of Buy-rated stocks in a recent Jefferies research piece, as they are all good stealth plays. That is, they are top companies, under the radar, that have a big impact in their...
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media and Wal-Mart.
These are the top 24/7 Wall St. blue chip upgrades, downgrades and initiations tracked for the week of September 9.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.